Bioscience Reports (2019) 39(4), BSR20182266; https://doi.org/10.1042/BSR20182266

The authors of the published article have made an error in Figure 2. The correct Figure 2 and its legend is as follows:

cIAP1 promotes the proliferation and migration of GBC in vitro

Figure 2
cIAP1 promotes the proliferation and migration of GBC in vitro

(A) The knocking-down efficiency of three siRNA oligo strings were testified by Western blot. (B) The knockdown efficiencies were confirmed by quantitated PCR at mRNA level. (C) The knockdown efficiencies were confirmed by Western blotting at protein level. (D) Designate stably lentivirus-transfected cells including NOZ and SGC-996 were established as LV-shcIAP1 with controls of LV-NC. (E) Twice as much GBC migrated to the lower chamber in LV-NC than the LV-shcIAP1(**P< 0.01,***P< 0. 001). (F) A periodical test by CCK-8 reveal LV-shcIAP1 cell lines exhibited less viability and proliferation rate in 72 h. (G) Fewer clones were presented in LV-shcIAP1 group in clone formation assay (**P< 0.01).All experiments were confirmed for at least three times.

Figure 2
cIAP1 promotes the proliferation and migration of GBC in vitro

(A) The knocking-down efficiency of three siRNA oligo strings were testified by Western blot. (B) The knockdown efficiencies were confirmed by quantitated PCR at mRNA level. (C) The knockdown efficiencies were confirmed by Western blotting at protein level. (D) Designate stably lentivirus-transfected cells including NOZ and SGC-996 were established as LV-shcIAP1 with controls of LV-NC. (E) Twice as much GBC migrated to the lower chamber in LV-NC than the LV-shcIAP1(**P< 0.01,***P< 0. 001). (F) A periodical test by CCK-8 reveal LV-shcIAP1 cell lines exhibited less viability and proliferation rate in 72 h. (G) Fewer clones were presented in LV-shcIAP1 group in clone formation assay (**P< 0.01).All experiments were confirmed for at least three times.

This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).